DK1051155T3 - Nasale opløsninger - Google Patents

Nasale opløsninger

Info

Publication number: DK1051155T3
Authority: DK; Denmark
Prior art keywords: nasal solutions; liquid; nasal; inter alia; relates
Prior art date: 1998-01-30

Application number

DK99904823T

Other languages

Danish (da)

English (en)

Inventor

Christopher Buckley

Matthias Seidel

Original Assignee

Novartis Consumer Health Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-30

Filing date

1999-01-28

Publication date

2002-09-16

1999-01-28 Application filed by Novartis Consumer Health Sa filed Critical Novartis Consumer Health Sa

2002-09-16 Application granted granted Critical

2002-09-16 Publication of DK1051155T3 publication Critical patent/DK1051155T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Otolaryngology (AREA)
Pulmonology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Compounds Of Unknown Constitution (AREA)

DK99904823T 1998-01-30 1999-01-28 Nasale opløsninger DK1051155T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP98810069		1998-01-30
PCT/EP1999/000555 WO1999038492A1 (fr)	1998-01-30	1999-01-28	Preparations pharmaceutiques

Publications (1)

Publication Number	Publication Date
DK1051155T3 true DK1051155T3 (da)	2002-09-16

Family

ID=8235913

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99904823T DK1051155T3 (da)	1998-01-30	1999-01-28	Nasale opløsninger

Country Status (12)

Country	Link
EP (1)	EP1051155B1 (fr)
JP (1)	JP4603687B2 (fr)
AT (1)	ATE219657T1 (fr)
AU (1)	AU741364B2 (fr)
CA (1)	CA2311530C (fr)
DE (1)	DE69901936T2 (fr)
DK (1)	DK1051155T3 (fr)
ES (1)	ES2180274T3 (fr)
IL (1)	IL136591A (fr)
NZ (1)	NZ505919A (fr)
PT (1)	PT1051155E (fr)
WO (1)	WO1999038492A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030059440A1 (en) *	1998-09-01	2003-03-27	Tim Clarot	Composition and method for moisturizing nasal tissue
PT1194145E (pt) *	1999-06-22	2003-06-30	Boehringer Ingelheim Int	Solucao estavel de xilometazolina e de oximetazolina
PL208686B1 (pl) *	2001-09-18	2011-05-31	Nycomed Danmark Aps	Kompozycja w postaci roztworu wodnego do leczenia przeziębienia oraz zastosowanie połączenia ipratropium lub jego soli i ksylometazoliny lub jej soli
BG65734B1 (bg) *	2002-02-22	2009-09-30	Био Терапютикс - Еоод	Течен мукоадхезивен фармацевтичен състав
EP1517673A1 (fr) *	2002-06-20	2005-03-30	Novartis Consumer Health S.A.	Compositions nasales contenant un glycosaminoglycane et un propylene glycol
AU2003272517A1 (en)	2002-09-13	2004-04-30	Zicam, Llc.	Compositions to reduce congestion and methods for application thereof to the nasal membrane
US20040235807A1 (en) *	2003-05-21	2004-11-25	Weinrich Karl P.	Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea
MXPA06000281A (es)	2003-06-30	2006-07-03	Johnson & Johnson	Formulaciones para microproyecciones revestidas que contienen contraiones no volatiles.
DE10337186A1 (de) *	2003-08-13	2005-03-17	Merck Patent Gmbh	Wässrige Wirkstoff-Lösung
JP4956981B2 (ja) *	2005-01-05	2012-06-20	大正製薬株式会社	オキシメタゾリン含有水性組成物
GB2423711B (en)	2005-10-24	2007-02-14	Fortune Apex Dev Ltd	Method for preparing a pharmaceutical composition with enhanced mucoadhesion
US8940796B2 (en)	2006-02-21	2015-01-27	Wyeth Llc	Phenylephrine liquid formulations
US20070249727A1 (en)	2006-04-21	2007-10-25	The Proctor & Gamble Company	Compositions and kits useful for treatment of respiratory illness
US10022339B2 (en)	2006-04-21	2018-07-17	The Procter & Gamble Company	Compositions and methods useful for treatment of respiratory illness
DE102008007198A1 (de) *	2008-02-01	2009-08-13	Infectopharm Arzneimittel Und Consilium Gmbh	Oral oder nasal applizierbare Epinephrin- haltige Zubereitungen mit verbesserten Eigenschaften
AR073796A1 (es) *	2008-10-10	2010-12-01	Schering Corp	Formulaciones de corticosteroides y sus metodos de tratamiento
DE102013001151A1 (de)	2013-01-24	2014-07-24	Merz Pharma Gmbh & Co. Kgaa	Sprühbare flüssige Zubereitung zur insbesondere nasalen Anwendung mit erhöhter lokaler Verweilzeit
PL2759290T3 (pl)	2013-01-24	2020-03-31	Merz Pharma Gmbh & Co. Kgaa	Płynny preparat w aerozolu do stosowania donosowego z wydłużonym miejscowym czasem działania
DE202013000748U1 (de)	2013-01-24	2013-02-19	Merz Pharma Gmbh & Co. Kgaa	Sprühbare flüssige Zubereitung zur insbesondere nasalen Anwendung mit erhöhter lokaler Verweilzeit
WO2014158118A1 (fr) *	2013-03-29	2014-10-02	Santa Farma İlaç Sanayi̇ A.Ş.	Composition de suspension contenant de ipratropium et de oxymétazoline
EP2978407B1 (fr) *	2013-03-29	2020-05-06	Santa Farma Ilaç Sanayi A.S.	Composition de solution aqueuse contenant de l'ipratropium et de l'oxymétazoline
JP6039861B2 (ja)	2013-07-17	2016-12-07	ダウグローバルテクノロジーズエルエルシー	ヒドロキシアルキルメチルセルロースを含む粘膜適用組成物
WO2015047762A1 (fr) *	2013-09-25	2015-04-02	Dow Global Technologies Llc	Composition pour application à une muqueuse comprenant un éther de cellulose
EA032719B1 (ru) *	2014-12-24	2019-07-31	Ярдан-Галенски Лабораторий Д.Д.	Назальная лекарственная форма против заложенности носа
EP3612173B1 (fr) *	2017-04-17	2023-10-11	Hikma Pharmaceuticals USA Inc.	Formulations pour la pulvérisation d'épinéphrine
CN112512506A (zh) *	2018-06-13	2021-03-16	希克玛药物美国股份有限公司	肾上腺素喷雾制剂
CA3110773C (fr)	2018-09-11	2023-02-28	Lead Biotherapeutics Ltd.	Systeme de nanoparticules de dispersion mucoadhesives et procede de fabrication

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS62292719A (ja) *	1986-06-12	1987-12-19	Kaken Pharmaceut Co Ltd	外用澄明水溶性製剤
MY102411A (en) *	1986-12-23	1992-06-17	Ciba Geigy Ag	Nasal solutions
JPH04327533A (ja) *	1991-04-23	1992-11-17	Lion Corp	抗アレルギー用粘膜局所投与剤
ATE158172T1 (de) *	1992-05-26	1997-10-15	Procter & Gamble	Pulverförmige pharmazeutische zusammensetzung
CA2101126A1 (fr) *	1992-08-03	1994-02-04	Yasushi Morita	Preparation pour traitement topique
EP0689438B1 (fr) *	1993-03-26	2003-06-04	Franciscus Wilhelmus Henricus Maria Merkus	Compositions pharmaceutiques pour l'administration intranasale d'apomorphine
JPH07109228A (ja) *	1993-10-08	1995-04-25	Earth Chem Corp Ltd	リゾチーム配合口腔用組成物
CA2156255C (fr) *	1993-12-17	2008-02-05	Yasuyuki Kunihiro	Dispositif a semi-conducteur
JP3269770B2 (ja) *	1995-03-02	2002-04-02	参天製薬株式会社	再分散性の優れたイオン性高分子配合水性懸濁点眼剤
DE19549421C2 (de) *	1995-11-10	1999-11-18	Klosterfrau Mcm Vetrieb Gmbh	Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
AU9281698A (en) *	1997-10-01	1999-04-23	Wakamoto Pharmaceutical Co., Ltd.	O/w emulsion compositions

1999
- 1999-01-28 PT PT99904823T patent/PT1051155E/pt unknown
- 1999-01-28 AU AU25198/99A patent/AU741364B2/en not_active Expired
- 1999-01-28 AT AT99904823T patent/ATE219657T1/de active
- 1999-01-28 IL IL13659199A patent/IL136591A/xx not_active IP Right Cessation
- 1999-01-28 CA CA002311530A patent/CA2311530C/fr not_active Expired - Lifetime
- 1999-01-28 EP EP99904823A patent/EP1051155B1/fr not_active Expired - Lifetime
- 1999-01-28 DK DK99904823T patent/DK1051155T3/da active
- 1999-01-28 JP JP2000529226A patent/JP4603687B2/ja not_active Expired - Lifetime
- 1999-01-28 DE DE69901936T patent/DE69901936T2/de not_active Expired - Lifetime
- 1999-01-28 WO PCT/EP1999/000555 patent/WO1999038492A1/fr not_active Ceased
- 1999-01-28 NZ NZ505919A patent/NZ505919A/xx not_active IP Right Cessation
- 1999-01-28 ES ES99904823T patent/ES2180274T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
PT1051155E (pt)	2002-10-31
CA2311530A1 (fr)	1999-08-05
JP4603687B2 (ja)	2010-12-22
JP2002501884A (ja)	2002-01-22
IL136591A0 (en)	2001-06-14
EP1051155B1 (fr)	2002-06-26
AU2519899A (en)	1999-08-16
AU741364B2 (en)	2001-11-29
DE69901936T2 (de)	2002-11-28
EP1051155A1 (fr)	2000-11-15
WO1999038492A1 (fr)	1999-08-05
DE69901936D1 (de)	2002-08-01
IL136591A (en)	2005-08-31
NZ505919A (en)	2002-10-25
CA2311530C (fr)	2008-06-10
ATE219657T1 (de)	2002-07-15
ES2180274T3 (es)	2003-02-01

Publication	Publication Date	Title
DE69901936D1 (de)	2002-08-01	Nasale lösungen
BR0214343A (pt)	2004-09-14	Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
ES2162951T3 (es)	2002-01-16	Estabilizacion de composiciones de prostaglandina.
TR200101499T1 (tr)	2002-09-23	Azepinoindol türevleri, hazırlanmaları ve kullanımları.
TR199901411T2 (xx)	1999-09-21	Analjezik etkili yeni bile�imler.
NO20024339D0 (no)	2002-09-11	1,2,3,4-Tetrahydroisokinolin-derivater
NO970051L (no)	1997-01-07	Vandige risperidon formuleringer
MXPA04001256A (es)	2004-05-27	Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
AU3227700A (en)	2000-08-29	Skin sanitizing compositions
TNSN04034A1 (en)	2006-06-01	Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
BR0014355A (pt)	2002-07-16	Derivados de sapogenina e seu uso no tratamento de disfunção cognitiva
HUP0101498A1 (hu)	2002-03-28	Dexmedetomidin alkalmazása nyugtató hatású gyógyszerkészítmények előállítására
TR200100455T2 (tr)	2001-07-23	Nimesulid içeren topikal farmasötik bileşimler
BR0114912A (pt)	2003-10-14	Kahalalide f
SE9801494D0 (sv)	1998-04-28	Novel use
DE69911388D1 (de)	2003-10-23	Orale antimikrobielle und desodoriende zusammensetzungen
DK1092431T3 (da)	2006-12-18	Lasofoxifenpræparater
PT1107793E (pt)	2005-02-28	Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
MXPA03011128A (es)	2004-03-19	Composicion de sabor y fragancia.
BR0206960A (pt)	2004-03-09	Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
DK0977871T3 (da)	2006-01-16	Neurotrypsin
BR9907426A (pt)	2000-09-19	Tetrahidronaftalenos
DE60003074D1 (de)	2003-07-03	Fusidinsäure-derivate
MD1473G2 (ro)	2001-05-31	Remediu antiherpetic
BR0213463A (pt)	2004-11-09	Composições farmacêuticas contendo macrólidos